A reversible monoamine oxidase A inhibitor, befloxatone : Structural approach of its mechanism of action

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 7; no. 8; pp. 1683 - 1693
Main Authors WOUTERS, J, MOUREAU, F, EVRARD, G, KOENIG, J.-J, JEGHAM, S, GEORGE, P, DURANT, F
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Science 01.08.1999
Subjects
Biological and medical sciences
Medical sciences
Neuropharmacology
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Haloalcohol
Ab initio method
Psychotropic
Active site
Conformational analysis
Lipophily
Inhibitor enzyme complex
Organic carbamate
X ray diffraction
Modeling
Three dimensional model
Hydroxyether
MAO A inhibitor
Molecular model
Befloxatone
Antidepressant agent
Benzenic compound
Fluorine Organic compounds
Mechanism of action
AM1 method
Oxygen nitrogen heterocycle
Electrostatic model
Ultraviolet visible spectrometry
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0968-0896
1464-3391
DOI:10.1016/s0968-0896(99)00102-9